Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study.
Although rare over most of the world, Gallbladder cancer is very common in northern india. A delayed presentation, aggressive nature,lack of randomised trials and a poor prognosis have all contributed to the nihilistic halo encircling gallbladder cancer. None of the advances in oncology have been exploited enough to shatter the nihilistic halo. In this background we sought to analyze if the addition of neoadjuvant chemotherapy had any impact on the resectability, overall and disease free survival in patients with advanced carcinoma of the gallbladder. We reviewed the records of all patients who underwent surgery for carcinoma of the gall bladder from 2004 to 2010 at our institute retrospectively. Twenty-one patients received neoadjuvant chemotherapy and subsequently taken up for surgery. Outcome analysis of these 21 patients were done by Kaplan meier method and graphs plotted. Out of the 21 patients who were taken up for surgery after neoadjuvant chemotherapy, fourteen patients underwent R0 resection (Group 1). Seven patients had been rendered inoperable on exploration (Group 2). Thus about 66.67 % of patients deemed resectable after neoadjuvant chemotherapy on imaging underwent R0 resection. The mean overall survival of the group 1 was 42.8 months versus 6.6 months of group 2(Hazard Ratio: 3.42). Neoadjuvant chemotherapy improves resectability in some patients with unresectable gall bladder cancer. Resection after neoadjuvant chemotherapy is feasible and may improve survival in a select group of patients. However randomized studies are required to establish its definitive role.
Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Sector V, Rohini, Delhi 110085 India.
Veda Padma Priya
VP
Selvakumar
Department of Surgical Oncology Indraprastha Apollo Hospital, Rohini, Delhi 110085 India.
Shuaib
S
Zaidi
Department of Surgical Oncology Max Cancer Care & Superspeciality Hospital, Patparganj, Delhi India.
Pankaj
P
Pande
Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Sector V, Rohini, Delhi 110085 India.
Ashish
A
Goel
Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Sector V, Rohini, Delhi 110085 India.
Kapil
K
Kumar
Advanced carcinoma gall bladder; Neoadjuvant chemotherapy